Preventive effects of Suvorexant on delirium at postoperative hip surgery: arandomized placebo-controlled trial
Latest Information Update: 21 Apr 2021
At a glance
- Drugs Suvorexant (Primary)
- Indications Delirium
- Focus Therapeutic Use
- 19 Apr 2021 Status changed from recruiting to discontinued.
- 05 Oct 2016 New trial record